FSD Pharma Engages Totaligent for Market Awareness Campaign

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A), a biopharmaceutical firm, has announced a new collaboration with Totaligent, Inc. Totaligent will help enhance FSD's market awareness and shareholder engagement. The partnership aims to leverage Totaligent's 25 years of experience and extensive investor database.

Totaligent has been contracted for a 30-day term, with a fee of $30,000 USD. Either party can terminate the agreement with five business days' notice. The contract commenced on June 28, 2024.

Additionally, FSD Pharma issued 650,000 Class B Subordinate Voting shares to settle debts amounting to $195,000. These shares were valued at $0.30 each and were issued to independent creditors.